Prof. Haihui Huang (Shanghai, China)
Prof. Haihui Huang is a Chief Physician, Professor, Doctoral Supervisor, and Deputy Director of the Institute of Antibiotics at Huashan Hospital, Fudan University. Prof. Huang also serves as the Deputy Director of the Key Laboratory of Antibiotic Clinical Pharmacology of the National Health Commission. She is the incoming Chairperson of the Infection and Chemotherapy Branch of the Shanghai Medical Association and leads the Bacterial Infection and Antimicrobial Resistance Prevention and Control Group. Furthermore, Prof. Huang is a member of the Drug Therapy Committee of the Shanghai Pharmaceutical Association and the Secretary of the Committee on Drug Evaluation of the Chinese Pharmaceutical Association.
Prof. Huang has long been dedicated to the clinical diagnosis and treatment of complex and refractory infections caused by drug-resistant bacteria and fungi across various body sites, as well as the diagnosis and management of Fever of Unknown Origin (FUO). She has a particular focus on intractable infections in immunocompromised patients, such as those undergoing liver and kidney transplants. In recent years, she has led over ten international multi-center (China region) and domestic clinical trials for new anti-infective drugs and has participated in the formulation of six guidelines on antibacterial drugs by the Center for Drug Evaluation, NMPA.
Her primary research interests include bacterial resistance mechanisms, infections in immunocompromised populations, and the development and application of new antibacterial drugs. As the principal investigator, she has undertaken three projects funded by the National Natural Science Foundation of China, one sub-project under a Major Program of the Ministry of Science and Technology of China, and six provincial and ministerial-level projects. She has also been selected for the Shanghai Pujiang Talent Program.
Prof. Haihui Huang is a Chief Physician, Professor, Doctoral Supervisor, and Deputy Director of the Institute of Antibiotics at Huashan Hospital, Fudan University. Prof. Huang also serves as the Deputy Director of the Key Laboratory of Antibiotic Clinical Pharmacology of the National Health Commission. She is the incoming Chairperson of the Infection and Chemotherapy Branch of the Shanghai Medical Association and leads the Bacterial Infection and Antimicrobial Resistance Prevention and Control Group. Furthermore, Prof. Huang is a member of the Drug Therapy Committee of the Shanghai Pharmaceutical Association and the Secretary of the Committee on Drug Evaluation of the Chinese Pharmaceutical Association.
Prof. Huang has long been dedicated to the clinical diagnosis and treatment of complex and refractory infections caused by drug-resistant bacteria and fungi across various body sites, as well as the diagnosis and management of Fever of Unknown Origin (FUO). She has a particular focus on intractable infections in immunocompromised patients, such as those undergoing liver and kidney transplants. In recent years, she has led over ten international multi-center (China region) and domestic clinical trials for new anti-infective drugs and has participated in the formulation of six guidelines on antibacterial drugs by the Center for Drug Evaluation, NMPA.
Her primary research interests include bacterial resistance mechanisms, infections in immunocompromised populations, and the development and application of new antibacterial drugs. As the principal investigator, she has undertaken three projects funded by the National Natural Science Foundation of China, one sub-project under a Major Program of the Ministry of Science and Technology of China, and six provincial and ministerial-level projects. She has also been selected for the Shanghai Pujiang Talent Program.